Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply.

IF 6.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Alimentary Pharmacology & Therapeutics Pub Date : 2024-11-19 DOI:10.1111/apt.18401

Simon Woelfel, Stephan Brand

引用次数: 0

查看原文本刊更多论文

社论：更新的 COVID-19 增效剂--为 IBD 患者提供量身定制的保护。作者回复。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.